Search the Newsreel

Phathom Pharmaceuticals (PHAT) Stock Sees Modest Fair Value Cut After Analyst Target Cuts

Phathom Pharmaceuticals (PHAT) has experienced a modest fair value cut from US$23.70 to US$21.50 following analyst target revisions. This adjustment is due to updated Q2 results, revised 2026 revenue guidance, and new perspectives on their drug Voquezna's commercial path. While some firms remain bullish …

Option Care Health, Inc. (NASDAQ:OPCH) Given Average Rating of "Moderate Buy" by Brokerages

Option Care Health, Inc. (NASDAQ:OPCH) has received a consensus "Moderate Buy" rating from 14 analysts, with seven rating it a "buy" and seven a "hold." The average 12-month price target is $29.92, surpassing its current share price of $23.94, despite some recent analyst downgrades …

Strathcona Resources Ltd. (TSE:SCR) Receives Average Recommendation of "Buy" from Analysts

LifeStance Health Group, Inc. (NASDAQ:LFST) Receives Average Recommendation of "Moderate Buy" from Analysts

Analysts have given LifeStance Health Group (NASDAQ:LFST) a consensus "Moderate Buy" rating, with an average 12-month price target of $12.13. The company recently surpassed quarterly earnings expectations, reporting an EPS of $0.06 against an estimated $0.03 and revenues of $435.35 million, a 26.1% year-over-year …

Wall Street Zen Upgrades Avalo Therapeutics (NASDAQ:AVTX) to Hold

Wall Street Zen has upgraded Avalo Therapeutics (NASDAQ:AVTX) from a "sell" to a "hold" rating, though the consensus among other analysts remains a "Moderate Buy" with an average price target of $45.10. The company reported a quarterly loss of $0.83 per share, missing estimates. …

Atara Biotherapeutics (NASDAQ:ATRA) Rating Increased to Hold at Wall Street Zen

Wall Street Zen has upgraded Atara Biotherapeutics (NASDAQ:ATRA) from "Sell" to "Hold," reflecting an average "Hold" consensus among analysts with an average price target of $9.50. Despite the upgrade, ATRA shares opened down 4.9% at $8.09, with the company reporting a quarterly loss of …

Smith & Nephew SNATS (NYSE:SNN) Stock Rating Lowered by Wall Street Zen

Wall Street Zen downgraded Smith & Nephew SNATS (NYSE:SNN) from a "buy" to a "hold" rating, contributing to a mixed analyst sentiment with an overall "Hold" consensus and a $30.93 price target. The stock opened at $29.84, trading below its 50-day and 200-day moving …

Orthofix (OFIX) Q2 2026 Earnings Call Transcript

Image source: The Motley Fool. DATE Wednesday, Aug. 5, 2026 at 8:30 a.m. ET CALL PARTICIPANTS Chief IR and Communications Officer - Julie Dewey President and Chief Executive Officer - Massimo Calafiore Chief Financial Officer - Julie Andrews Full Conference Call Transcript Operator: Thank …

AdaptHealth (NASDAQ:AHCO) Downgraded to "Sell" Rating by Wall Street Zen

Wall Street Zen has downgraded AdaptHealth (NASDAQ:AHCO) from a "hold" to a "sell" rating, despite the broader consensus of "Moderate Buy" among analysts with an average price target of $10.29. The company's shares opened at $5.81, near their 52-week low, and below their 50-day …

Compass Pathways (NASDAQ:CMPS) Raised to "Sell" at Wall Street Zen

Wall Street Zen has downgraded Compass Pathways (CMPS) from "strong sell" to "sell," despite the broader analyst consensus remaining a "Moderate Buy" with a $23.36 target price. The company's shares opened at $13.45, reflecting a 1.2% increase, and it recently reported a quarterly loss …

From Apache to Boeing: Israeli AI Company Takes Its AI to the Next Level

Israeli AI company Odysight.ai, whose computer-vision technology is currently used on Israeli Air Force Apache helicopters, has signed an agreement with Boeing. This Memorandum of Agreement allows Odysight.ai to demonstrate its visual sensing and predictive-maintenance platform at two Boeing sites. The collaboration signifies a …

1 Healthcare Stock Worth Your Attention and 2 We Brush Off

1 Healthcare Stock Worth Your Attention and 2 We Brush Off Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Shareholders who bet on the industry have been rewarded lately as healthcare stocks have returned 26.1% …

Should I buy Scribe Therapeutics Inc. (SCTX)

Enterprise value to revenue forward of Rhythm Pharmaceuticals, Inc. – DUS:1RV

This article provides financial data for Rhythm Pharmaceuticals, Inc. (DUS:1RV) on the Dusseldorf Stock Exchange, specifically focusing on its enterprise value to revenue forward. It notes that the market is closed with no trades recorded at the time of publication. The content is presented …

Oak Valley Bancorp (OVLY) Stock Hinges On Durable Margin Strength

Coca-Cola (NYSE:KO) steadies as consumer staples payers draw attention

Coca-Cola (NYSE:KO) garnered attention this week after raising its full-year guidance, reinforcing its position as a stable consumer staples payer known for consistent dividend increases over six decades. The company's diversified portfolio, global reach, and disciplined operations contribute to its reliability, especially as market …

Can American Airlines Close The Profit Gap With Delta & United?

American Airlines lags significantly behind Delta and United in profitability, with a 0.2% net margin compared to Delta's 7.9% and United's 5.7%. This gap is attributed to past strategic errors, including a reduced long-haul presence and a failed attempt to force corporate bookings direct. …

Seritage Growth Properties (SRG) Stock Faces Shrinking Revenue Despite Narrower Losses

Canopy Growth (NASDAQ:CGC) stock in focus after revenue growth and margin gains

Sherwin Williams (SHW) Unveils Water Based Spray Paint For Indoor And Outdoor Use

Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. Sherwin-Williams (NYSE:SHW) brand Krylon has introduced Krylon Harmony, a new water-based spray paint designed for year-round indoor and outdoor use. The product aims …

Price-Driven Insight from (ZVRA) for Rule-Based Strategy

This article provides a price-driven analysis for Zevra Therapeutics Inc. (NASDAQ: ZVRA), highlighting weak near-term sentiment but strong mid and long-term outlooks. It details institutional trading strategies including position, momentum breakout, and risk hedging, along with multi-timeframe signal analysis, and an exceptional risk-reward short …

Arcutis (ARQT) Q2 2026 Earnings Call Transcript

Discipline and Rules-Based Execution in WS Response

Worthington Steel Inc. (NYSE: WS) shows a near-term neutral sentiment amidst mid and long-term strength, with a current mid-channel oscillation pattern. AI models have generated three trading strategies (Position, Momentum Breakout, Risk Hedging) tailored to different risk profiles. The analysis highlights an exceptional 54.5:1 …

Patriot National Bancorp (PNBK) Stock Profit Return Still Leaves Doubts

North American Construction Group Ltd (NOA) (Q2 2026) Earnings Call Highlights: Record Revenue ... By GuruFocus

North American Construction Group Ltd. (NOA) reported its Q2 2026 earnings, with revenue increasing by 19.8% to $282.2 million, and cash from operating activities rising significantly by 34.6% to $64.0 million. Despite this, operating profit and net income saw decreases, and diluted EPS fell …

Sigma Lithium (SGML) Stock Rallies On Record Revenue But Losses Linger

Smith Midland (SMID) Stock Price Trails Profit Squeeze And Value Gap

Nektar Therapeutics (NKTR) Stock Slides As Cash Burn Clouds Pipeline Progress

Nektar Therapeutics' stock fell 4% following its Q2 2026 earnings report, despite progress in its autoimmune pipeline, notably rezpegaldesleukin. The market reacted negatively to the company's substantial cash burn, with a quarterly net loss exceeding US$40 million and trailing 12-month losses widening. While the …

Orthofix Medical Sees Reimbursement Rebound, but Spine Slump Clouds Outlook

Orthofix Medical's updated outlook reflects a rebound in bone growth stimulation reimbursement and improved trends in biologics and limb reconstruction, partially offset by a steeper-than-expected decline among smaller U.S. spine distributors. The company expects third-quarter revenue to be similar to the second quarter with …

Will Rising Revenue But Mounting Losses and Steady Payouts Change Brookfield Wealth Solutions' (BNT) Narrative

TJX Companies (TJX) Nears Earnings, Is The 14% Undervaluation Case Convincing?

Brookfield Wealth Solutions Ltd. (NYSE:BNT) Short Interest Update

Hongkong & Shanghai Hotels Signals Earnings Turnaround

How can Disney get back its narrative momentum?

Investing.com -- Walt Disney (NYSE:DIS) must rebuild its franchise pipeline and become a larger content aggregator if it wants to regain the valuation premium it historically commanded, Barclays analysts said. Disney's valuation has fallen toward multi-decade lows as investors have focused on near-term earnings …

Is Berkshire’s Bigger Bet on Delta (DAL) Altering The Investment Case For The Airline?

In recent filings, Berkshire Hathaway disclosed that it added millions of Delta Air Lines shares while also reshaping its broader equity portfolio, including exiting Constellation Brands and trimming its Bank of America stake. This increased exposure places Delta alongside Berkshire's core holdings such as …

Income Investors Should Know That Jardine Matheson Holdings Limited (SGX:J36) Goes Ex-Dividend Soon